Merck wins FDA priority review for KEYTRUDA bladder cancer combo expansion
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The plant is currently scaling towards a production capacity of nearly 3 million gloves per day
The cleanroom operates under stringent ISO Class 5 conditions, using ultrapure water and air systems
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
Subscribe To Our Newsletter & Stay Updated